# LIDOCAINE HYDROCHLORIDE AND DEXTROSE

NDC: 51662-1657
Generic name: LIDOCAINE HYDROCHLORIDE AND DEXTROSE
Labeler / Manufacturer: HF Acquisition Co LLC, DBA HealthFirst
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 19810422

FDA application: NDA018461

## Active ingredients

- LIDOCAINE HYDROCHLORIDE: 8 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51662-1657"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51662-1657
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1bf999b5-e290-dcbd-e063-6294a90a2bab
